Spruce Biosciences, Inc. announced that Dr. Javier Szwarcberg, M.D., MPH, has been appointed as a member of the board of directors. Samir Gharib, MBA, has been concurrently promoted to President and will continue in his role as Chief Financial Officer. The promotion of Samir Gharib to President follows his service as Chief Financial Officer of Spruce since May 2020 and reflects an evolution of the company's leadership structure. In this new role, Mr. Gharib will lead the finance, business and corporate development, investor relations, corporate communications, human resources,
legal and information technology functions at Spruce.